Table 3

 DGL5 113A variant allele frequency, carrier frequency, heterozygote frequency, and homozygote frequency in the inflammatory bowel disease, Crohn’s disease, ulcerative colitis, and control populations

ControlsIBD (p value)Crohn’s disease (p value)Ulcerative colitis (p value)
The p values shown are calculated between the control group and each respective disease group.
Allelic frequency13.2%11.4% p = 0.3011.4% p = 0.3711.4% p = 0.34
Carrier frequency63/256 (24.6%)125/652 (19.2%) p = 0.06965/356 (18.3%) p = 0.05760/296 (20.3%) p = 0.228
Heterozygosity rates59/256 (23%)110/650 (16.7%) p = 0.03357/356 (16%) p = 0.02953/294 (18%) p = 0.45
Homozygosity rates4/256 (1.5%)15/650 (2.3%) p = 0.488/356 (2.2%) p = 0.367/294 (2.4%) p = 0.50